Issued Patents All Time
Showing 1–23 of 23 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11666566 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2023-06-06 |
| 11033540 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2021-06-15 |
| 10966922 | Pharmaceutical formulations | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury | 2021-04-06 |
| 10166183 | Pharmaceutical formulations | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury | 2019-01-01 |
| 9814708 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2017-11-14 |
| 9550780 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2017-01-24 |
| 9346800 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2016-05-24 |
| 9296739 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2016-03-29 |
| 9233959 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas G. Gant +1 more | 2016-01-12 |
| 6858409 | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors | Robert C. Thompson, Charles H. Hannum, Stephen P. Eisenberg, William P. Arend, Fenneke G. Joslin | 2005-02-22 |
| 6599873 | Interleukin-1 inhibitors, compositions, and methods of treatment | Charles H. Hannum, Stephen P. Eisenburg, Robert C. Thompson, William P. Arend, Fenneke G. Joslin | 2003-07-29 |
| 6124259 | Method for treating ophthalmic disorders with IGFBP | Michael Delmage | 2000-09-26 |
| 6040292 | Methods for treating diabetes | — | 2000-03-21 |
| 5948757 | High dose IGF-1 therapy | Jerome Moore, Steven W. Adams | 1999-09-07 |
| 5789547 | Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding | Yasushi Ogawa, Peggy Tao | 1998-08-04 |
| 5643867 | Method for treating catabolic conditions | Christopher A. Maack | 1997-07-01 |
| 5407913 | Method and composition for systemic treatment of tissue injury | Christopher A. Maack | 1995-04-18 |
| 5332804 | High molecular weight human angiogenic basic fibroblast growth factors | Robert Florkiewicz | 1994-07-26 |
| 5188943 | Method of producing high molecular weight human fibroblast growth factors | Robert Florkiewicz | 1993-02-23 |
| 5112404 | Pigment formulations, processes for their preparation and their use | Erwin Dietz, Manfred Urban | 1992-05-12 |
| 5070159 | Addition compounds, a process for the preparation, and their use, based on epoxy novolac-fatty amine adducts | Erwin Dietz, Adolf Kroh, Jurgen Hohn, Otmar Hafner, Wolfgang Rieper | 1991-12-03 |
| 5026839 | DNA encoding a basic fibroblast growth factor | David A. Moscatelli, Daniel B. Rifkin | 1991-06-25 |
| 4994559 | Human basic fibroblast growth factor | David A. Moscatelli, Daniel B. Rifkin | 1991-02-19 |